What will be the next successful commercial application of optical coherence tomography (OCT)? "I expect it will be GI (gastrointestinal) or perhaps pulmonary" imaging, says Greg Smolka, author of the research report Optical Coherence Tomography 2010: Technology, Applications, and Markets.
In a webcast today, Smolka talked about signs to look for to determine which application is really gaining traction. He also recapped some recent progress in technology (e.g., combining OCT with other imaging modalities) and markets/applications (the FDA approved OCT for 3 additional specialty applications in 2010-and more approvals are coming).
Listening to Smolka's presentation, I was reminded how truly important OCT is--how its speed and resolution empower medical clinicians in critical ways. And though it's made an enormous impact in ophthalmology already, its true utility has yet to be understood. Get ready for a fascinating ride.
Those registered for the event can get a 20% discount on a report ordered within 2 weeks of today's broadcast (courtesy of Strategies Unlimited). The full presentation itself will be posted within 24 hours.
Thursday, February 17, 2011
Monday, February 14, 2011
Previewed at BiOS ’11--Part 1
During BiOS/Photonics West 2011, I got to see a number of newly released products (see recent new product postings and stay tuned for later blog entries)--and to preview products not yet available.
During BiOS/Photonics West 2011, I got to see a number of newly released products (see recent new product postings and stay tuned for later blog entries)--and to preview products not yet available.
For instance, I learned about the latest version of Imagine Eyes’s rtx1 Adaptive Optics Retinal Camera, for which they had just received the first orders. The first device of its kind as far as I know, it features automated adaptive optics and captures en face cellular-level images of the retina in vivo without pupil dilation. It reportedly can discern things that optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) cannot, and produces 1200 x 1200 micron images that can be tiled together to view larger areas. Imagine Eyes is now marketing to researchers, and expects FDA approval in about a year. Meantime the company is building a morphological image database and gathering feedback from clinical partners including France’s national ophthalmic center.
During BiOS/Photonics West 2011, I got to see a number of newly released products (see recent new product postings and stay tuned for later blog entries)--and to preview products not yet available.
For instance, I learned about the latest version of Imagine Eyes’s rtx1 Adaptive Optics Retinal Camera, for which they had just received the first orders. The first device of its kind as far as I know, it features automated adaptive optics and captures en face cellular-level images of the retina in vivo without pupil dilation. It reportedly can discern things that optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) cannot, and produces 1200 x 1200 micron images that can be tiled together to view larger areas. Imagine Eyes is now marketing to researchers, and expects FDA approval in about a year. Meantime the company is building a morphological image database and gathering feedback from clinical partners including France’s national ophthalmic center.
Subscribe to:
Posts (Atom)